| Elisa Amador, | |
|
12428 S Mossberg Dr, Herriman, UT 84096-7784 | |
| (801) 493-5945 | |
| Not Available |
| Full Name | Elisa Amador |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Women's Health |
| Location | 12428 S Mossberg Dr, Herriman, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023620168 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SW0102X | Clinical Nurse Specialist - Women's Health | 9806346-3102 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elisa Amador, 12428 S Mossberg Dr, Herriman, UT 84096-7784 Ph: (801) 493-5945 | Elisa Amador, 12428 S Mossberg Dr, Herriman, UT 84096-7784 Ph: (801) 493-5945 |
News Archive
"When a person receives a cancer diagnosis his or her life is completely transformed and all of the sudden they have so few choices," said Laura Morrell, social worker at Loyola University Health System's Cardinal Bernardin Cancer Center. Thirty-five women and one man who attend the Divine Savior Parish in Downers Grove, Ill., are helping to bring choice back into cancer patients' lives.
Non-small cell lung cancer patients with advanced disease receiving standard of care treatment have a higher overall survival than similar patients not receiving treatment.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) shows that RNA nanoparticles have elastic and rubbery properties that help explain why these particles target tumors so efficiently and why they possess lower toxicity in animal studies.
Biotech 2009 (www.biotech2009.org) will bring together globally-recognized industry leaders to address key trends and topics relevant to the growth and advancement of the tri-state region's bioscience industry.
QuantaLife, a new life science tool company developing the third generation of PCR, has received an NIH grant totaling ~$6 million over 5 years for the development of rapid, cost-effective technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) infections. The grant, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, will fund the project.
› Verified 1 days ago
Mrs. Sharon Renae Davis, FNP - BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5869 W Muirwood Dr, Herriman, UT 84096 Phone: 801-450-8403 |